Jacobson Pharma (HKSE:02633) EPS (Basic) : HK$0.13 (TTM As of Sep. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Jacobson Pharma EPS (Basic)?

Jacobson Pharma's basic earnings per share (Basic EPS) for the six months ended in Sep. 2024 was HK$0.07. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2024 was HK$0.13.

Jacobson Pharma's EPS (Diluted) for the six months ended in Sep. 2024 was HK$0.07. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was HK$0.13.

Jacobson Pharma's EPS without NRI for the six months ended in Sep. 2024 was HK$0.07. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2024 was 0.13.

During the past 12 months, Jacobson Pharma's average EPS without NRIGrowth Rate was 26.20% per year. During the past 3 years, the average EPS without NRI Growth Rate was 8.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was -1.50% per year. During the past 10 years, the average EPS without NRI Growth Rate was 3.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 11 years, Jacobson Pharma's highest 3-Year average EPS without NRI Growth Rate was 24.20% per year. The lowest was -10.30% per year. And the median was 2.50% per year.

Jacobson Pharma EPS (Basic) Historical Data

The historical data trend for Jacobson Pharma's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jacobson Pharma EPS (Basic) Chart

Jacobson Pharma Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EPS (Basic)

Get a 7-Day Free Trial

0.11

0.09

0.13

0.14

Jacobson Pharma Semi-Annual Data
	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
EPS (Basic)	Get a 7-Day Free Trial															0.07	0.06	0.08	0.06	0.07

Jacobson Pharma EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Jacobson Pharma's Basic EPS for the fiscal year that ended in Mar. 2024 is calculated as

Basic EPS (A: Mar. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(266.968	-	0)	/	1911.361
	=	0.14

Jacobson Pharma's Basic EPS for the quarter that ended in Sep. 2024 is calculated as

Basic EPS (Q: Sep. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(140.29	-	0)	/	1983.948
	=	0.07

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.13

Jacobson Pharma (HKSE:02633) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Jacobson Pharma EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Jacobson Pharma's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Jacobson Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jacobson Pharma Corp Ltd (HKSE:02633) » Definitions » EPS (Basic)

Traded in Other Exchanges

N/A

Address

388 Kwun Tong Road, Unit 2313-18, 23rd Floor, Tower 1, Millennium City 1, Kwun Tong, Kowloon, Hong Kong, HKG

Website

http://www.jacobsonpharma.com

Jacobson Pharma Corp Ltd is an investment holding company. It is principally engaged in the development, production, marketing, and sale of generic drugs. The company's operating segment includes Generic drugs; Branded healthcare, Wholesale, and retail The generic drugs segment develops, manufactures, and distributes a host of off-patent medicines for various therapeutic use. It generates maximum revenue from the Generic drugs segment. Geographically, it derives a majority of its revenue from Hong Kong and also has a presence in Mainland China, Macau, Singapore, and Other Countries.

Executives

Queenshill Development Limited
Sum Kwong Yip, Derek	2305 Beneficiary of a trust
Lau Wing Hung
Kingshill Development Group Inc
Kingshill Development Limited
Ubs Trustees (b.v.i.) Limited
Longjin Investments Limited
Yun Nan Bai Yao Ji Tuan Gu Fen You Xian Gong Si

Jacobson Pharma Headlines

No Headlines